Status and phase
Conditions
Treatments
About
A single-arm, multi-center study to verify that knee joint function at 52 weeks after injection of FF-31501 is better than at screening in patients with meniscus tear who are eligible for meniscectomy .
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients with suspected meniscal flap tear
Patients with knee pain
Patients with one or more of the following symptoms
Other
Exclusion criteria
Patients with poor knee alignment
Patients who underwent meniscus surgery or platelet rich plasma therapy
Patients with or history of knee ligament injury
Diabetic patients with poor glycemic control
Patients with the following complications and poor general condition
Patients who are pregnant or possibly pregnant and/or breast-feeding, or patients planning to become pregnant during the study period
Other
Primary purpose
Allocation
Interventional model
Masking
18 participants in 1 patient group
Loading...
Central trial contact
FUJIFILM Toyama Chemical Co., Ltd
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal